AzentaAZTA
About: Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has two reportable segments that are Life Sciences Products and Life Sciences Services. It generates a substantial part of its revenue from its Life Sciences Services segment.
Employees: 3,300
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
14% more call options, than puts
Call options by funds: $14.9M | Put options by funds: $13M
1.42% more ownership
Funds ownership: 99.06% [Q1] → 100.48% (+1.42%) [Q2]
0% more funds holding in top 10
Funds holding in top 10: 2 [Q1] → 2 (+0) [Q2]
2% less funds holding
Funds holding: 321 [Q1] → 316 (-5) [Q2]
12% less first-time investments, than exits
New positions opened: 38 | Existing positions closed: 43
14% less capital invested
Capital invested by funds: $3.33B [Q1] → $2.85B (-$478M) [Q2]
31% less repeat investments, than reductions
Existing positions increased: 92 | Existing positions reduced: 133
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
2 analyst ratings
Evercore ISI Group Vijay Kumar 80% 1-year accuracy 24 / 30 met price target | 15%upside $50 | In-Line Maintained | 1 Oct 2024 |
Needham David Saxon 28% 1-year accuracy 17 / 61 met price target | 59%upside $69 | Buy Reiterated | 7 Aug 2024 |
